Squadron Capital Management LLC
38 holdingsFiling period: 2026-06-30Current AUM: $263.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RLMD | Relmada Therapeutics Inc | 7.35M | $50.9M | $24.7M | 9.36% | -1,124,571 | 2026-06-30 |
| 2 | CCCC | C4 Therapeutics Inc | 7.60M | $35.5M | $24.0M | 9.10% | +5.35M | 2026-06-30 |
| 3 | COGT | Cogent Biosciences Inc | 865.0K | $33.5M | $27.0M | 10.24% | +77.5K | 2026-06-30 |
| 4 | ZNTL | Zentalis Pharmaceuticals Inc | 4.13M | $20.0M | $9.9M | 3.74% | +95.0K | 2026-06-30 |
| 5 | KOD | Kodiak Sciences Inc | 500.0K | $19.5M | $46.5M | 17.62% | +120.0K | 2026-06-30 |
| 6 | RLAY | Relay Therapeutics Inc | 970.0K | $18.1M | $17.9M | 6.78% | +147.5K | 2026-06-30 |
| 7 | EWTX | Edgewise Therapeutics Inc | 290.0K | $11.8M | $11.5M | 4.37% | -60,000 | 2026-06-30 |
| 8 | MAZE | Maze Therapeutics Inc | 335.0K | $10.0M | $10.9M | 4.12% | +77.5K | 2026-06-30 |
| 9 | BIOA | Bioage Labs Inc | 405.0K | $9.9M | $2.3M | 0.85% | -- | 2026-06-30 |
| 10 | IVA | Inventiva SA | 2.44M | $9.2M | $7.9M | 3.01% | +1.90M | 2026-06-30 |
| 11 | ANL | Adlai Nortye Ltd | 764.9K | $8.8M | $8.1M | 3.09% | -500,355 | 2026-06-30 |
| 12 | CMPS | Compass Pathways PLC | 605.0K | $8.6M | $7.2M | 2.73% | -- | 2026-06-30 |
| 13 | ELVN | Enliven Therapeutics Inc | 160.0K | $8.1M | $6.6M | 2.50% | -- | 2026-06-30 |
| 14 | RZLT | Rezolute Inc | 1.30M | $6.8M | $4.8M | 1.83% | -- | 2026-06-30 |
| 15 | AVBP | Arrivent Biopharma Inc | 183.0K | $6.4M | $3.4M | 1.31% | +73.0K | 2026-06-30 |
| 16 | PALI | Palisade Bio Inc | 3.00M | $6.3M | $4.3M | 1.63% | -- | 2026-06-30 |
| 17 | IKT | Inhibikase Therapeutics Inc | 3.00M | $6.1M | $5.1M | 1.94% | -500,000 | 2026-06-30 |
| 18 | ADAG | Adagene Inc | 1.25M | $5.3M | $3.1M | 1.18% | -- | 2026-06-30 |
| 19 | FBRX | Forte Biosciences Inc | 225.0K | $4.8M | $4.8M | 1.81% | -- | 2026-06-30 |
| 20 | — | Inflarx NV | 2.00M | $4.5M | $4.5M | 1.70% | -- | 2026-06-30 |
| 21 | ASMB | Assembly Biosciences Inc | 160.0K | $4.4M | $3.4M | 1.29% | -- | 2026-06-30 |
| 22 | PMN | Promis Neurosciences Inc | 325.0K | $4.3M | $2.6M | 1.00% | -- | 2026-06-30 |
| 23 | CTNM | Contineum Therapeutics Inc | 260.0K | $4.3M | $2.2M | 0.83% | -- | 2026-06-30 |
| 24 | DFTX | Definium Therapeutics Inc | 85.0K | $4.0M | $3.0M | 1.13% | -- | 2026-06-30 |
| 25 | — | Sol-Gel Technologies Ltd | 52.0K | $3.9M | $3.9M | 1.46% | +21.0K | 2026-06-30 |
← Scroll →
Page 1 of 2